Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Neurosciences
May 18, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community